Genmab A (GMAB) Intangibles (2018 - 2026)

Genmab A has reported Intangibles for 7 years, with the latest figure at $8.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Intangibles rose 409.57% year-over-year to $8.9 billion; the trailing twelve-month figure through Mar 2026 stood at $8.9 billion (up 409.57% YoY), and the FY2025 full-year result was $9.1 billion, up 427.95% from the prior year.
• Intangibles for Q1 2026 stood at $8.9 billion, down from $9.1 billion in the prior quarter.
• The five-year high for Intangibles was $9.1 billion in Q4 2025, with the low at $15.0 million in Q4 2023.
• Historically, Intangibles has averaged $3.6 billion across 4 years, with a median of $1.8 billion in 2025.
• Annual changes were most pronounced in 2024 — Intangibles soared 11420.0% — and 2026, when it jumped 409.57%.
• Genmab A's Intangibles stood at $15.0 million in 2023, then soared by 11420.0% to $1.7 billion in 2024, then surged by 427.95% to $9.1 billion in 2025, then declined by 1.92% to $8.9 billion in 2026.
• The last three Intangibles figures came in at $8.9 billion (Q1 2026), $9.1 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.